BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12457032)

  • 1. Clinical application of oligonucleotide probe array for full-length gene sequencing of TP53 in colon cancer.
    Takahashi Y; Ishii Y; Nagata T; Ikarashi M; Ishikawa K; Asai S
    Oncology; 2003; 64(1):54-60. PubMed ID: 12457032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of alterations affecting the p53 pathway in bladder cancer on clinical outcome, assessed by conventional and array-based methods.
    Lu ML; Wikman F; Orntoft TF; Charytonowicz E; Rabbani F; Zhang Z; Dalbagni G; Pohar KS; Yu G; Cordon-Cardo C
    Clin Cancer Res; 2002 Jan; 8(1):171-9. PubMed ID: 11801555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of TP53 mutations with the AmpliChip p53 research test in chronic lymphocytic leukemia: correlation with clinical outcome and gene expression profiling.
    Chiaretti S; Tavolaro S; Marinelli M; Messina M; Del Giudice I; Mauro FR; Santangelo S; Piciocchi A; Peragine N; Truong S; Patten N; Ghia EM; Torrente I; De Propris MS; Nanni M; Lawrence J; Guarini A; Foà R
    Genes Chromosomes Cancer; 2011 Apr; 50(4):263-74. PubMed ID: 21319261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of TP53 mutations identified by oligonucleotide microarray and conventional DNA sequence analysis.
    Wen WH; Bernstein L; Lescallett J; Beazer-Barclay Y; Sullivan-Halley J; White M; Press MF
    Cancer Res; 2000 May; 60(10):2716-22. PubMed ID: 10825146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of TP53 germline mutations in pediatric tumor patients using DNA microarray-based sequencing technology.
    Schaefer KL; Wai D; Poremba C; Diallo R; Boecker W; Dockhorn-Dworniczak B
    Med Pediatr Oncol; 2002 Apr; 38(4):247-53. PubMed ID: 11920788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid p53 sequence analysis in primary lung cancer using an oligonucleotide probe array.
    Ahrendt SA; Halachmi S; Chow JT; Wu L; Halachmi N; Yang SC; Wehage S; Jen J; Sidransky D
    Proc Natl Acad Sci U S A; 1999 Jun; 96(13):7382-7. PubMed ID: 10377423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in tumour suppressor gene p53 correlate with inhibition of thrombospondin-1 gene expression in colon cancer cells.
    Tokunaga T; Nakamura M; Oshika Y; Tsuchida T; Kazuno M; Fukushima Y; Kawai K; Abe Y; Kijima H; Yamazaki H; Tamaoki N; Ueyama Y
    Virchows Arch; 1998 Nov; 433(5):415-8. PubMed ID: 9849855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TP53 gene mutations and CCND1 gene amplification in head and neck squamous cell carcinoma cell lines.
    Xu L; Davidson BJ; Murty VV; Li RG; Sacks PG; Garin-Chesa P; Schantz SP; Chaganti RS
    Int J Cancer; 1994 Nov; 59(3):383-7. PubMed ID: 7927946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of aberrations of 17p and p53 gene in gastrointestinal cancers by dual (two-color) fluorescence in situ hybridization and GeneChip p53 assay.
    Takahashi Y; Nagata T; Asai S; Shintaku K; Eguchi T; Ishii Y; Fujii M; Ishikawa K
    Cancer Genet Cytogenet; 2000 Aug; 121(1):38-43. PubMed ID: 10958939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of oligonucleotide arrays for sequencing of the p53 gene in DNA from formalin-fixed, paraffin-embedded breast cancer specimens.
    Cooper M; Li SQ; Bhardwaj T; Rohan T; Kandel RA
    Clin Chem; 2004 Mar; 50(3):500-8. PubMed ID: 14726466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low density DNA microarray for detection of most frequent TP53 missense point mutations.
    Rangel-López A; Maldonado-Rodríguez R; Salcedo-Vargas M; Espinosa-Lara JM; Méndez-Tenorio A; Beattie KL
    BMC Biotechnol; 2005 Feb; 5():8. PubMed ID: 15713227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid and sensitive p53 alteration analysis in biopsies from lung cancer patients using a functional assay and a universal oligonucleotide array: a prospective study.
    Fouquet C; Antoine M; Tisserand P; Favis R; Wislez M; Commo F; Rabbe N; Carette MF; Milleron B; Barany F; Cadranel J; Zalcman G; Soussi T
    Clin Cancer Res; 2004 May; 10(10):3479-89. PubMed ID: 15161705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TP53 mutations and abnormal p53 protein staining in breast carcinomas related to prognosis.
    Thorlacius S; Thorgilsson B; Björnsson J; Tryggvadottir L; Börresen AL; Ogmundsdottir HM; Eyfjörd JE
    Eur J Cancer; 1995 Oct; 31A(11):1856-61. PubMed ID: 8541113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer.
    Berns EM; Foekens JA; Vossen R; Look MP; Devilee P; Henzen-Logmans SC; van Staveren IL; van Putten WL; Inganäs M; Meijer-van Gelder ME; Cornelisse C; Claassen CJ; Portengen H; Bakker B; Klijn JG
    Cancer Res; 2000 Apr; 60(8):2155-62. PubMed ID: 10786679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the TP53 gene in laser-microdissected glioblastoma vasculature.
    Kulla A; Burkhardt K; Meyer-Puttlitz B; Teesalu T; Asser T; Wiestler OD; Becker AJ
    Acta Neuropathol; 2003 Apr; 105(4):328-32. PubMed ID: 12624785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Harmonized microarray/mutation scanning analysis of TP53 mutations in undissected colorectal tumors.
    Favis R; Huang J; Gerry NP; Culliford A; Paty P; Soussi T; Barany F
    Hum Mutat; 2004 Jul; 24(1):63-75. PubMed ID: 15221790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
    Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TP53 mutations in astrocytic gliomas: an association with histological grade, TP53 codon 72 polymorphism and p53 expression.
    Faria MH; Neves Filho EH; Alves MK; Burbano RM; de Moraes Filho MO; Rabenhorst SH
    APMIS; 2012 Nov; 120(11):882-9. PubMed ID: 23009112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 gene point mutations in relation to p53 nuclear protein accumulation in colorectal cancers.
    Costa A; Marasca R; Valentinis B; Savarino M; Faranda A; Silvestrini R; Torelli G
    J Pathol; 1995 May; 176(1):45-53. PubMed ID: 7616356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of analysis of p53 alteration and observation of surface microstructure for diagnosis of ulcerative colitis-associated colorectal neoplasia.
    Fujii S; Fujimori T; Chiba T
    J Exp Clin Cancer Res; 2003 Mar; 22(1):107-15. PubMed ID: 12725330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.